QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

dreamstime page 1 m 28518973

The genetics of prostate cancer

At the annual meeting of the Society of Urologic Oncology (SUO) held in the fall of 2023, Dr. Catalona gave an invited lecture to urologic oncologists on the Genetics of Prostate Cancer. This article is a condensation and simplification of…

Read More
IMG 4586 page 6A or IMG 4545

Andrew Fox walks away without a scratch

Andrew Fox’s lifetime love affair with trains has provided him with a vocation, an   avocation, and plenty of adventures. Andrew grew up in northern California and from an early age was fascinated by trains. He got his first job…

Read More
IMG 4853 P8

Receipt of novel hormonal therapy varies by race

A recent study reported differences in the use of novel hormonal therapy (NHT) among Medicare beneficiaries with advanced prostate cancer (PC) based on their race. Researchers studied how NHT was used among men diagnosed with advanced PC between January 1,…

Read More
kittens by fire page 9A

New approach for mCRPC

New study results found that Cabozantinib plus Atezolizumab (C+A) can significantly   improve prognoses of patients with metastatic castration-resistant prostate cancer (mCRPC) that has progressed with prior novel hormonal therapy. This phase 3 study, found that patients in the C+A…

Read More
dreamstime page 10A l 185358114

Two treatment methods for advanced prostate cancer

A recent phase II trial compared two treatments for advanced prostate cancer. One treatment used lutetium-177 [177Lu] Lu-PSMA- 617, and the other used cabazitaxel. Both treatments were given to men whose cancer had spread after receiving docetaxel. The study looked…

Read More

Subscribe to Quest

"*" indicates required fields


This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*